Anika Therapeutics, Inc. Inventory, Noncurrent
Anika Therapeutics, Inc. (ANIK) had Inventory, Noncurrent of $2.58 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:InventoryNoncurrent · last filed 2026-07-29
- 2026-06-30: Inventory, Noncurrent $2.58M.
- 2026-03-31: Inventory, Noncurrent $3.84M.
- 2025-12-31: Inventory, Noncurrent $3.55M.
- 2025-09-30: Inventory, Noncurrent $5.11M.
| Period end | Inventory, Noncurrent | Inventory, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $2.58M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $3.84M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $3.55M 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $5.11M 10-Q · filed 2025-11-05 | |
| 2025-06-30 | $5.11M 10-Q · filed 2025-07-30 | |
| 2025-03-31 | $5.24M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $5.13M 10-K · filed 2026-03-03 | |
| 2024-09-30 | $10.72M 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $19.14M 10-Q · filed 2024-08-08 | |
| 2024-03-31 | $17.17M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $5.26M 10-K · filed 2025-03-17 | $18.21M 10-K · filed 2024-03-15 |
| 2023-09-30 | $18.38M 10-Q · filed 2023-11-03 | |
| 2023-06-30 | $18.80M 10-Q · filed 2023-08-08 | |
| 2023-03-31 | $17.63M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $16.72M 10-K · filed 2024-03-15 | |
| 2022-09-30 | $17.70M 10-Q · filed 2022-11-09 | |
| 2022-06-30 | $20.18M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $19.53M 10-Q · filed 2022-05-06 | |
| 2021-12-31 | $19.04M 10-K · filed 2023-03-16 | |
| 2021-09-30 | $22.80M 10-Q · filed 2021-11-05 | |
| 2021-06-30 | $17.73M 10-Q · filed 2021-08-06 | |
| 2020-12-31 | $14.80M 10-K · filed 2022-03-11 | |
| 2020-09-30 | $12.72M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $12.97M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $19.45M 10-Q · filed 2021-05-07 | $27.07M 10-Q · filed 2020-05-22 |
| 2019-12-31 | $7.17M 10-K/A · filed 2021-04-26 | |
| 2019-09-30 | $5.44M 10-Q · filed 2019-10-28 | |
| 2019-06-30 | $4.54M 10-Q · filed 2019-07-26 | |
| 2019-03-31 | $3.64M 10-Q · filed 2019-05-06 | |
| 2018-12-31 | $3.83M 10-K · filed 2020-03-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |